Showing results (101-110 of 668) with videos related to
Sort By:
Pageof 67
Advances in Pharmacology (San Diego, Calif.)|September 24, 2013
Catecholamine/Serotonin interactions: systems thinking for brain function and diseaseJulie G Hensler, Francesc Artigas, Analía Bortolozzi, et al.Advances in Pharmacology (San Diego, Calif.)|September 24, 2013
The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episodeIlaria Bonoldi, O D HowesAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
AADC deficiency: occurring in humans, modeled in rodentsWuh-Liang Hwu, Ni-Chung Lee, Yin-Hsiu Chien, et al.Advances in Pharmacology (San Diego, Calif.)|September 24, 2013
Catecholamine receptors: prototypes for GPCR-based drug discoveryAndrew C EmeryAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
Pituitary adenylate cyclase-activating polypeptide (PACAP): a master regulator in central and peripheral stress responsesTomris MustafaAdvances in Pharmacology (San Diego, Calif.)|July 27, 2013
Antiviral agents for herpes simplex virusR Anthony Vere Hodge, Hugh J FieldAdvances in Pharmacology (San Diego, Calif.)|July 27, 2013
Nucleotide prodrugs for the treatment of HCV infectionMichael J SofiaAdvances in Pharmacology (San Diego, Calif.)|July 27, 2013
HIV integrase inhibitors: 20-year landmark and challengesMathieu Métifiot, Christophe Marchand, Yves PommierAdvances in Pharmacology (San Diego, Calif.)|July 27, 2013
Influenza virus resistance to antiviral therapyErhard van der Vries, Martin Schutten, Pieter Fraaij, et al.Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)Erik De ClercqPageof 67